Therapeutic inertia in diabetes management is the failure to initiate or intensify pharmacological treatment when a patient's glycated hemoglobin (HbA1c) goals are not me [...]

The United States continues to face a significant opioid epidemic, with adolescence representing a critical period of vulnerability. Opioid prescriptions during adolescen [...]

This dissertation describes nocturnal sleep–wake patterns in adolescents undergoing chemotherapy and examines relationships among sleep, treatment‑related symptoms, and q [...]

The FDA has received millions of reports of adverse events over the last ten years. A clinician's ability to identify potential drug-drug interactions in routine practice [...]

Rural communities are disproportionately impacted by the nation's current opioid epidemic. While access to buprenorphine, the gold standard of pharmaceutical treatment fo [...]

Patient activation reflects the knowledge, skills, beliefs, and behaviors individuals need to manage chronic illness, yet it has not been extensively studied among people [...]

Due to the complexity of BCR/ABL-independent TKI resistance, a central question is whether relapse acts through the canonical BCR/ABL CML pathways seen in dependent cases [...]

The Bcr‑Abl tyrosine kinase drives chronic myeloid leukemia (CML) and is the target of imatinib therapy, which induces complete cytogenetic responses in most patients. Ho [...]